The politics of valuation and payment for regenerative medicine products in the UK

Abstract : The field of regenerative medicine (RM) faces many challenges, including funding. Framing the analysis in terms of institutional politics, valuation studies and 'technologies of knowledge', the paper highlights growing debates about payment for RM in the UK, setting this alongside escalating policy debates about 'value'. We draw on interviews and publicly available material to identify the interacting and conflicting positions of institutional stakeholders. It is concluded that while there is some common ground between institutional stakeholders such as industry and health system gatekeepers, there is significant conflict about reward systems, technology assessment methodologies and payment scenarios; a range of mostly conditional payment schemes and non-mainstream routes are being experimented with. We argue that current developments highlight a fundamental conflict between a concern for the societal value of medical technologies in a resource-limited system and a concern for engineering new reward and payment models to accommodate RM innovations.
Document type :
Journal articles
Complete list of metadatas

https://halshs.archives-ouvertes.fr/halshs-01856030
Contributor : Aurélie Mahalatchimy <>
Submitted on : Wednesday, November 28, 2018 - 3:30:20 PM
Last modification on : Friday, December 7, 2018 - 2:30:03 PM

File

Accepted version.pdf
Files produced by the author(s)

Version pre-print

Identifiers

Collections

Citation

Alex Faulkner, Aurélie Mahalatchimy. The politics of valuation and payment for regenerative medicine products in the UK. New Genetics and Society, Taylor & Francis (Routledge), 2018, ⟨10.1080/14636778.2018.1487282⟩. ⟨halshs-01856030⟩

Share

Metrics

Record views

62

Files downloads

14